| Filed On | Filing |
|---|---|
| 27 Oct 2026 | SCHEDULE 13G/A |
| 29 Sep 2026 |
Form 4: Bair Teresa Brophy, Chief Legal Officer
Sold 8,442 shares ($88.6K) |
| 29 Sep 2026 |
Form 4: Ford Kathleen, Chief Operating Officer
Sold 6,906 shares ($72.5K) · Sold 3,668 shares ($39.4K) |
| 29 Sep 2026 |
Form 4: Leoni Mollie, Chief Medical Officer
Sold 12,448 shares ($131K) · Sold 28,802 shares ($310K) |
| 29 Sep 2026 |
Form 4: Doyle Thomas James, SVP, Finance & Accounting
Sold 4,607 shares ($48.4K) |
| 29 Sep 2026 |
Form 4: Powl Brian T., Chief Commercial Officer
Sold 17,020 shares ($179K) · Sold 15,430 shares ($166K) |
| 29 Sep 2026 | 144 |
| 29 Sep 2026 | 144 |
| 29 Sep 2026 | 144 |
| 28 Sep 2026 | 144 |
| 28 Sep 2026 | 144 |
| 28 Sep 2026 | 144 |
| 28 Sep 2026 | 144 |
| 28 Sep 2026 | 144 |
| 28 Sep 2026 | 144 |
| 25 Sep 2026 |
Form 4: Burrows Francis, Chief Scientific Officer
Received 30,000 shares by exercise or conversion ($185K) · Sold 20,726 shares ($225K) |
| 24 Sep 2026 | 144 |
| 10 Sep 2026 |
Form 4: Fulk Jennifer, Chief Financial Officer
Granted 450,000 Option to purchase common stock |
| 10 Sep 2026 |
Form 3: Fulk Jennifer, Chief Financial Officer
No securities owned |
| 09 Sep 2026 |
8-K: Other Events
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission. |
Loading...